Nociceptin/orphanin FQ peptide receptor antagonist JTC‐801 reverses pain and anxiety symptoms in a rat model of post‐traumatic stress disorder

Abstract

BACKGROUND AND PURPOSESingle-prolonged stress (SPS), a rat model of post-traumatic stress disorder (PTSD), also induces long-lasting hyperalgesia associated with hypocortisolism and elevated nociceptin/orphanin FQ (N/OFQ) levels in serum and CSF. Here, we determined the effect of JTC-801 (N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride), a nociceptin/orphanin FQ peptide (NOP) receptor antagonist, on symptoms of pain and anxiety in rats after SPS exposure, and examined N/OFQ-NOP receptor system changes. EXPERIMENTAL APPROACHMale Sprague Dawley rats received JTC-801 (6 mg kg −1 i.p., once daily) during days 7-21 of SPS. The ability of JTC-801 to inhibit N/OFQ-stimulated [ 35 S]-GTPγS binding was confirmed in rat brain membranes. Anxiety-like behaviour and pain sensitivity were monitored by changes in elevated plus maze performance and withdrawal responses to thermal and mechanical stimuli. Serum corticosterone and N/OFQ content in CSF, serum and brain tissues were determined by radioimmunoassay; NOP receptor protein and gene expression in amygdala, hippocampus and periaqueductal grey (PAG) were examined by immunoblotting and real-time PCR respectively. KEY RESULTSJTC-801 treatment reversed SPS-induced mechanical allodynia, thermal hyperalgesia, anxiety-like behaviour and hypocortisolism. Elevated N/OFQ levels in serum, CSF, PAG and hippocampus at day 21 of SPS were blocked by JTC-801; daily JTC-801 treatment also reversed NOP receptor protein and mRNA up-regulation in amygdala and PAG. CONCLUSION AND IMPLICATIONSJTC-801 reversed SPS-induced anxiety-and pain-like behaviours, and NOP receptor system up-regulation. These findings suggest that N/OFQ plays an important role in hyperalgesia and allodynia maintenance after SPS. NOP receptor antagonists may provide effective treatment for co-morbid PTSD and pain. LINKED ARTICLESThis article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx

Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

“…Because the NOP system is widely implicated in stressrelated pathophysiology (Zhang et al, 2012b(Zhang et al, , 2015 and recent evidence suggests that cykokines can also regulate mood and psychologic responses to stress (Zhu et al, 2010;Moretti et al, 2015), a better understanding how NOP cytokine signaling, extended into nonimmune cell types, will prove critical as we attempt to understand how NOP signaling functions to bidirectionally regulate the stress response.…”

Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors

“…BPN has low affinity for ORL-1 receptors, and we did not observe diminished activity of BPN's effects in the FST following systemic administration of JTC-801. At this dose JTC-801 is known to diminish allodynia and hyperalgesia in mice and reverse stress-induced behavioral deficits (Delaney et al, 2012;Yamada et al, 2002;Zhang et al, 2015). Numerous studies have shown that activation of ORL-1 receptors produces anxiolytic effects, whereas antagonism evokes antidepressant-like responses (Witkin et al, 2014).…”

Nociceptin and the nociceptin receptor in learning and memory

“…SPS is mainly used in rats. SPS elicits a deficit in fear extinction retention (Knox et al, 2012), has been shown to present enhanced N/OFQ levels in the hippocampus, cerebrospinal fluid and changes in allodynia and hyperalgesia (Zhang et al, 2014). …”